Skip to content

Baystate Business: Biotech and Politics

On the Tuesday, September 11 edition of Bloomberg Baystate Business we spoke with Dr. Pablo Cagnoni, CEO of Rubius Therapeutics, about the new technologies being developed by his company. Bloomberg…